RSS Feed
Featured Posts

Systematic screening required to detect endocrine complications after childhood cancer

As childhood cancer cure rates have substantially improved, the rate of late-onset endocrine complications among childhood cancer survivors has risen, with an estimated 50% of survivors experiencing complications ranging from thyroid dysfunction to obesity or type 2 diabetes during their lifetime, according to recent analyses. Read more: http://www.healio.com/endocrinology/pediatric-endocrinology/news/print/endocrine-today/%7Bfe817647-c149-49a9-a968-a8d13726f8c6%7D/systematic-screening-required-to-detect-endocrine-complications-after-childhood-cancer

Study for childhood cancer couples

A new study is recruiting participants! The study aims to document psychological and relationship adjustment in couples whose child has been diagnosed with pediatric cancer and has received cancer treatments in the past 2 years. Participating couples are invited to complete 3 online questionnaires over a period of 4 months. A financial compensation ($60/couple total through Amazon.ca gift card) is offered to thank participants for their time. Learn more:

Better detection may explain higher child cancer numbers: UN

Global childhood cancer rates jumped 13 percent in the decade to 2010 compared to the 1980s, according to a UN-backed study released Wednesday that says the increase may be due in part to improved detection. Read more at: https://medicalxpress.com/news/2017-04-higher-child-cancer.html#jCp

New potential treatment for aggressive brain cancer in children

Using state-of-the-art gene editing technology, scientists from Ann & Robert H. Lurie Children's Hospital of Chicago have discovered a promising target to treat atypical teratoid/rhabdoid tumor (AT/RT) - a highly aggressive and therapy resistant brain tumor that mostly occurs in infants. Read more: https://www.eurekalert.org/pub_releases/2017-04/arh-npt041117.php

Arm Measurements a Better Assessment of Nutritional Status in Childhood Cancer Survivors

Body mass index (BMI) is helpful in assessing the health of children and adolescents with cancer. However, it does not distinguish muscle from adipose tissue. Now, there may be an alternative to BMI for accessing children and adolescents with cancer. Read more: http://www.oncologynurseadvisor.com/general-oncology/arm-anthropometry-a-tool-to-assess-childhood-cancer-survivors/article/648441/

Parental Smoking Linked to Genetic Changes Found in Childhood Cancer

Smoking by either parent helps promote genetic deletions in children that are associated with the development and progression of the most common type of childhood cancer, according to research headed by UC San Francisco. Read more: https://scienceblog.com/493219/parental-smoking-linked-genetic-changes-found-childhood-cancer/#

Study finds more childhood cancer survivors would likely benefit from genetic screening

Twelve percent of childhood cancer survivors carry germline mutations that put them or their children at increased risk of developing cancer, according to a landmark study presented today at the annual meeting of the American Association for Cancer Research. Read more: https://eurekalert.org/pub_releases/2017-04/sjcr-sfm_1033017.php

Young cancer patients may lag peers in social functioning for years

Child and young adult cancer patients often struggle to lead a normal social life, and even two years after being diagnosed, many still have reduced functioning in the social realm, a recent study suggests. Read more: http://www.reuters.com/article/us-health-social-youth-cancer-idUSKBN17133Y

Premature ovarian insufficiency tied to pelvic radiotherapy, alkylating agent exposure

Women who had childhood cancer may have an increased risk for premature ovarian insufficiency after treatment with pelvic radiotherapy and alkylating agents, study data show. Read more: http://www.healio.com/endocrinology/reproduction-androgen-disorders/news/in-the-journals/%7Be3d8cc36-542e-4c3b-89ac-c034169eda0e%7D/premature-ovarian-insufficiency-tied-to-pelvic-radiotherapy-alkylating-agent-exposure

National Brain Tumor Society Launches Brain-Tumor Clinical Trial Finder

The National Brain Tumor Society (NBTS) announced the launch of a new brain-tumor clinical trial finder to engage patients in new research and ease the process of finding clinical trials. Read more: http://www.oncologynurseadvisor.com/brain-cancer/national-brain-tumor-society-clinical-trial-finder-treatment/article/647420/

Recent Posts
Archive
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • YouTube Social  Icon

524 Bayfield Street North
P.O. Box 20005
Barrie, ON L4M 5E9
Canada

info@opacc.org

1-888-290-5496

  • Wix Facebook page
  • Wix Twitter page
  • Instagram Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon